𝐌𝐞𝐝𝐭𝐫𝐨𝐧𝐢𝐜’𝐬 𝐉𝐨𝐮𝐫𝐧𝐞𝐲 (𝐏𝐚𝐫𝐭 𝐈𝐈): 𝐄𝐜𝐨𝐧𝐨𝐦𝐢𝐜 𝐎𝐮𝐭𝐩𝐮𝐭

In Part I, I discussed the evolution of Medtronic’s workforce over the past few decades. In this Part, I will focus on Medtronic’s economic output during the same period, in particular, its revenue (top-line) and earnings (bottom-line).

Historically, Medtronic has achieved growth in its core markets, resulting in steady revenue and profit growth. The development was achieved both organically and through a series of small and strategic tuck-in acquisitions that complemented the company’s existing offerings.

In January 2015, Medtronic completed its acquisition of Covidien (Medtronic Minimally Invasive Therapies Group) for $43 billion. The acquisition, which was more like a merger, garnered significant media attention, as it was the largest MedTech acquisition to date.

Although promising on paper, the acquisition presented substantial challenges for Medtronic. Before the acquisition of Covidien, Medtronic reported steady revenue growth, with a compound annual growth rate (CAGR) of over 5%, reaching $17 billion in 2014. Following the acquisition, Medtronic’s revenue nearly doubled, reaching $29 billion in 2016, making it the world’s largest medical device company by revenue. However, beyond the initial increase, Medtronic’s revenue remained essentially unchanged, with a compound annual growth rate (CAGR) of 1.5%, growing by only 10% over eight years, reaching $32 billion by 2024.

More importantly, despite doubling its revenue and workforce, Medtronic’s operating profit remained relatively unchanged at around $5 billion. This goes against what was initially promised by leadership, stating that “the acquisition will create a lot of synergy between the two entities.” Instead, the acquisition seems to have created further inefficiencies within the organization, which negatively impacted its bottom line.

In Part III, I will bring Part I & II together and quantify Medtronic’s operational efficiency over the years using standard metrics such as “Revenue Per Employee” and “Profit Per Employee”.